Eluminex nabs $50m Series A
Eluminex, an ophthalmic biotechnology company, has closed $50 million in Series A financing.
Eluminex, an ophthalmic biotechnology company, has closed $50 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination